Ovarian Cancer Clinical Trials
Find clinical trials for ovarian cancer. Search for ovarian cancer clinical trials in different cities and states across the United States.
AspirinUsing Aspirin to Improve Immunological Features of Ovarian Tumors
Sponsor:
H. Lee Moffitt Cancer Center and Research Institute
Location:
Code:
NCT05080946
Conditions
Ovarian Cancer
Fallopian Tube Cancer
Peritoneal Cancer
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Aspirin 325mg
Placebo
Beta3-Adrenergic AgonistsThe Physiological Responses and Adaptation of Brown Adipose Tissue to Chronic Treatment With Beta3-Adrenergic Receptor Agonists
Sponsor:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Location:
Code:
NCT03049462
Conditions
Polycystic Ovary Syndrome
Eligibility Criteria
Sex: All
Age: 18 - 40
Healthy Volunteers: Not accepted
Interventions
Mirabegron
B Complex Plus Vitamin C Tablets
BT8009Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies
Sponsor:
BicycleTx Limited
Location:
Code:
NCT04561362
Conditions
Urinary Bladder Neoplasm
Triple Negative Breast Neoplasms
Hormone Receptor Positive, HER2-negative Neoplasms
Hormone Receptor Positive, HER2-low Neoplasms
Breast Neoplasms
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
BT8009
Pembrolizumab
PF-08046054A Study of SGN-PDL1V in Advanced Solid Tumors
Sponsor:
Seagen Inc.
Location:
Code:
NCT05208762
Conditions
Carcinoma, Non-Small-Cell Lung
Squamous Cell Carcinoma of the Head and Neck
Esophageal Squamous Cell Carcinoma
Ovarian Neoplasms
Melanoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
PF-08046054
pembrolizumab
NX-1607A Study of NX-1607 in Adults With Advanced Malignancies
Sponsor:
Nurix Therapeutics, Inc.
Location:
Code:
NCT05107674
Conditions
Ovarian Cancer, Epithelial
Gastric Cancer
GastroEsophageal Junction (GEJ) Cancer
Head and Neck Squamous Cell Carcinoma
Metastatic or Unresectable Melanoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
NX-1607
Paclitaxel
Chemotherapy with Endocrine TherapyEvaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Sponsor:
NRG Oncology
Location:
Code:
NCT05879926
Conditions
Breast Cancer
Eligibility Criteria
Sex: Female
Age: 18 - 60
Healthy Volunteers: Not accepted
Interventions
Ovarian Function Suppression + Aromatase Inhibitor
Adjuvant Chemotherapy + Ovarian Function Suppression
AOH1996AOH1996 for the Treatment of Refractory Solid Tumors
Sponsor:
City of Hope Medical Center
Location:
Code:
NCT05227326
Conditions
Refractory Malignant Solid Neoplasm
Osteosarcoma
Leiomyosarcomas
Synovial Sarcomas
Ovarian Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
PCNA Inhibitor AOH1996
FRαDCsFolate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients with Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial
Sponsor:
Mayo Clinic
Location:
Code:
NCT06639074
Conditions
Advanced Fallopian Tube Carcinoma
Advanced Fallopian Tube High Grade Serous Adenocarcinoma
Advanced Ovarian Carcinoma
Advanced Ovarian Carcinosarcoma
Advanced Ovarian Clear Cell Adenocarcinoma
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Biopsy
Biospecimen Collection
Computed Tomography
Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed
Leukapheresis
[225Ac]-FPI-1434A Phase 1/2 Study of [225Ac]-FPI-1434 Injection
Sponsor:
Fusion Pharmaceuticals Inc.
Location:
Code:
NCT03746431
Conditions
Advanced Solid Tumours
Endometrial Cancer
Cervical Cancer
Ovarian Cancer
Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
[111In]-FPI-1547 Injection
[225Ac]-FPI-1434 Injection multi-dose
FPI-1175 Infusion
[225Ac]-FPI-1434 Injection single-dose
Observational StudyASk Questions in GYnecologic Oncology (ASQ-GYO)
Sponsor:
Ira Winer
Location:
Code:
NCT06339827
Conditions
Ovarian Cancer
Endometrial Cancer
Cervical Cancer
Vulvar Cancer
Vaginal Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Administration of the ASk Questions in GYnecologic Oncology (ASQ-GYO) Question Prompt List